SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001640334-20-002100
Filing Date
2020-08-13
Accepted
2020-08-13 18:35:11
Documents
1
Period of Report
2020-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 A form4a.html 4/A  
1 FORM 4 A form4a.xml 4/A 3779
  Complete submission text file 0001640334-20-002100.txt   5708
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Emerald Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OFFICE 8262 THE LANDING, 200-375 WATER ST. VANCOUVER A1 V6B 0M9
Business Address OFFICE 8262 THE LANDING, 200-375 WATER ST. VANCOUVER A1 V6B 0M9 858-361-4499
Emerald Health Sciences Inc. (Reporting) CIK: 0001728413 (see all company filings)

State of Incorp.: A1 | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 000-55136 | Film No.: 201100657